Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1369646 | Bioorganic & Medicinal Chemistry Letters | 2012 | 6 Pages |
Abstract
The second-generation synthesis of 3′-hydroxypacidamycin D (2) has been accomplished via an Ugi-four component reaction at a late stage of the synthesis. This approach provided ready access to a range of analogues including diastereomers of the diaminobutylic acid residue and hybrid-type analogues of mureidomycins. Biological evaluations of these analogues indicated that the stereochemistry at the diaminobutylic acid residue has a crucial impact on both the MraY biochemical inhibition and whole-cell antibacterial activity.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Kazuya Okamoto, Masahiro Sakagami, Fei Feng, Fumiyo Takahashi, Kouichi Uotani, Hiroko Togame, Hiroshi Takemoto, Satoshi Ichikawa, Akira Matsuda,